Qvt Financial LP Roivant Sciences Ltd. Transaction History
Qvt Financial LP
- $1.02 Billion
- Q4 2024
A detailed history of Qvt Financial LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Qvt Financial LP holds 65,793,779 shares of ROIV stock, worth $722 Million. This represents 76.3% of its overall portfolio holdings.
Number of Shares
65,793,779
Previous 65,793,779
-0.0%
Holding current value
$722 Million
Previous $759 Million
2.51%
% of portfolio
76.3%
Previous 73.2%
Shares
5 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$681 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$524 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$484 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$388 Million0.01% of portfolio
-
Morgan Stanley New York, NY34.6MShares$380 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.73B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...